«Wolman Disease

Below is an extended Wolman Disease patents listing. Click here to return to the Wolman Disease main in depth entry.

Patents :
US Patent No.	Title
6903201	Proteins and nucleic acids encoding same
7125843	Glycoconjugates including more than one peptide
7135322	Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester .alpha.-N-acetyl glucosimanidase
7138371	Remodeling and glycoconjugation of peptides
7157277	Factor VIII remodeling and glycoconjugation of Factor VIII
7173003	Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
7179617	Factor IX: remolding and glycoconjugation of Factor IX
7179629	Regulation of human serine/threonine kinase
7214660	Erythropoietin: remodeling and glycoconjugation of erythropoietin
7226903	Interferon beta: remodeling and glycoconjugation of interferon beta
7232667	Keratinocyte growth factor-2 polynucleotides
7122354	Nucleic acid encoding a chimeric polypeptide
7108972	Proteins, polynucleotides encoding them and methods of using the same
7101838	Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
6905816	Clinically intelligent diagnostic devices and methods
6905827	Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
6905856	Soluble GlcNAc phosphotransferase
6916473	Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
6946126	Replicating adenovirus vectors
6974667	Gene expression profiles in liver cancer
7015037	Multiponent adult stem cells and methods for isolation
7026121	Methods and compositions for diagnosing and monitoring transplant rejection
7034010	Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
7067127	GIcNAc phosphotransferase of the lysosomal targeting pathway
7232670	Targeting proteins to cells expressing mannose receptors via expression in insect cells
7241442	Method for producing proteins suitable for treating lysosomal storage disorders
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7371366	GlcNAc phosphotransferase of the lysosomal targeting pathway
7378231	Diagnosis of lysosomal storage disorders using saposins and other markers
7396811	Subcellular targeting of therapeutic proteins
7399613	Sialic acid nucleotide sugars
7399638	Prediction method for lipidosis
7411051	Antibodies to HDPPA04 polypeptide
7413903	Methods of regulating differentiation in stem cells
7415358	Molecular toxicology modeling
7368270	Human phospholipases
7361481	Diagnosis of lysosomal storage disorders using saposins and other markers
7358086	Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
7264926	Nucleoside Phosphatase
7265084	Glycopegylation methods and proteins/peptides produced by the methods
7265085	Glycoconjugation methods and proteins/peptides produced by the methods
7276475	Remodeling and glycoconjugation of peptides
7276593	Proteins and nucleic acids encoding same
7285631	Human cDNAs and proteins and uses thereof
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7297511	Interferon alpha: remodeling and glycoconjugation of interferon alpha
7329529	Ubiqutin proteases
7338781	Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
7416858	Pharmaceutical compositions of glycoconjugates

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.